Showing results (301-310 of 359) with videos related to
Sort By:
Pageof 36
Blood|February 9, 2026
A Randomized Phase 2 Study of Ipilimumab, Nivolumab, and Brentuximab Vedotin in Patients with Relapsed Hodgkin LymphomaCatherine Diefenbach, Opeyemi Jegede, Victoria Wang, et al.Cancer Discovery|February 2, 2019
Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 as Therapeutic Target for Enhancing Immune RecognitionDaisuke Ennishi, Katsuyoshi Takata, Wendy Béguelin, et al.Cell|July 4, 2020
TBL1XR1 Mutations Drive Extranodal Lymphoma by Inducing a Pro-tumorigenic Memory FateLeandro Venturutti, Matt Teater, Andrew Zhai, et al.Blood|October 29, 2020
The impact of MYC and BCL2 structural variants in tumors of DLBCL morphology and mechanisms of false-negative MYC IHCBrett Collinge, Susana Ben-Neriah, Lauren Chong, et al.Haematologica|May 6, 2021
MAPK and JAK-STAT pathways dysregulation in plasmablastic lymphomaJoan Enric Ramis-Zaldivar, Blanca Gonzalez-Farre, Alina Nicolae, et al.Nature Medicine|September 15, 2015
The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma developmentAna Ortega-Molina, Isaac W Boss, Andres Canela, et al.Blood|January 9, 2014
Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissueDavid W Scott, George W Wright, P Mickey Williams, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2022
Smart Start: Rituximab, Lenalidomide, and Ibrutinib in Patients With Newly Diagnosed Large B-Cell LymphomaJason Westin, R Eric Davis, Lei Feng, et al.Blood Cancer Discovery|June 24, 2026
A Patient-Derived Xenograft Repository Capturing Clinical and Molecular Heterogeneity of Large B-cell LymphomaHaopeng Yang, Kotaro Arita, Kevin Bowman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 23, 2021
ROBUST: A Phase III Study of Lenalidomide Plus R-CHOP Versus Placebo Plus R-CHOP in Previously Untreated Patients With ABC-Type Diffuse Large B-Cell LymphomaGrzegorz S Nowakowski, Annalisa Chiappella, Randy D Gascoyne, et al.Pageof 36